The Antimicrobial Susceptibility Testing market size is USD 6.6 Bn in 2026.
The Antimicrobial Susceptibility Testing market is projected to grow at a CAGR of 7% by 2033.
The market growth is driven by rising infectious disease prevalence, increasing antimicrobial resistance, growing antibiotic consumption, and technological advancements in rapid AST methods.
North America is a dominating region for the Antimicrobial Susceptibility Testing market.
bioMérieux S.A., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Roche Diagnostics, and Siemens Healthineers AG are some leading industry players in the Antimicrobial Susceptibility Testing market.